Does Age Impact Safety and Efficacy During Pulse-Field Ablation for Atrial Fibrillation?

ABSTRACT:

Background

There is no evidence evaluating efficiency, effectiveness, and safety outcomes in older patients in the context of pulsed-field ablation technology for the ablation of atrial fibrillation. We aimed to compare safety, efficacy, and acute and long-term outcomes of pulsed-field ablation in older patients (≥75 years) with younger ones.

Methods

We enrolled consecutive patients who had undergone atrial fibrillation ablation with the pulsed-field ablation FARAPULSE system (Boston Scientific) at 15 centers. Patients were stratified by age (<65, 65-74, and ≥75 years) and efficacy and safety profiles of these groups were compared.

Results

A total of 1082 patients were included: 108 (10%) were ≥75 years old, 374 (34.6%) were 65-74 years old and 600 (55.4%) were <65 ye

SUBMITTER: Dello Russo A 

PROVIDER: S-EPMC12184239 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature